The Progress Profile: Alzheimer’s Research in Focus podcast is back for another season of critical conversations about Alzheimer’s and brain health, building on the conversations from season 1 to learn more about neurodegenerative disease.

Check out the podcast episodes below!

⬆
  1. Ep. 3 Awareness and Advocacy: Scaling Impact Across Neurogenerative Diseases
  2. Ep. 2 Policy, Equity, and the Expanding Dementia Landscape
  3. Ep. 1 From Trials to Patients—Bridging Science and Lived Experience

Ep. 3

Awareness and Advocacy: Scaling Impact Across Neurogenerative Diseases

What could earlier detection, blood-based diagnostics, and emerging therapies mean for the future of Alzheimer’s disease? In Episode 3 of The Progress Profile: Alzheimer’s Research in Focus, Maria Carrillo, Ph.D., of the Alzheimer’s Association, joins Dr. John Harrison to explore the scientific advances and critical questions shaping the field. From the promise of prevention to the ethics of early biomarker testing, the conversation examines how progress can translate into meaningful improvements for patients and families. They also tackle misinformation, stigma, and discrimination, and what it takes to advance Alzheimer’s care responsibly.

Ep. 2

Policy, Equity, and the Expanding Dementia Landscape

In Episode 2 of The Progress Profile: Alzheimer’s Research in Focus, Dr. John Harrison, Alzheimer’s disease specialist, welcomes Dr. Phyllis Ferrell, MBA, innovator, investor, and incubator for brain health and longevity. Their conversation explores why scientific progress alone isn't enough to transform dementia care. They also discuss how to improve early diagnosis, the role of inequalities in cognitive health across communities, sex differences in brain health, and how lessons from Alzheimer's disease can advance care and research for other neurodegenerative conditions.

Ep. 1

From Trials to Patients—Bridging Science and Lived Experience

This premier episode of The Progress Profile: Alzheimer’s Research in Focus podcast brings together Dr. John Harrison, Dr. Lon Schneider, and Dr. Stephen Salloway as they discuss how to bridge the gap between clinical trial design and frontline care, exploring how insights from Alzheimer’s research are informing more patient-centered approaches to treatment, measurement, and long-term disease management.